Hydrochloric Acid

Hydrochloric Acid

SCHEMBL7264173

CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)O.Cl

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACE known ✓ P12821 11/20 0.59
PDE3A known ✓ Q14432 1/20 0.52
REN known ✓ P00797 1/20 0.51
LMNA P02545 2/20 0.59
ABCB11 O95342 2/20 0.57
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
USP2 O75604 1/20 0.55
CYP3A4 P08684 1/20 0.55
ALOX15 P16050 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10535372 1.00 ACE (0.59) ACELMNAABCB11MEN1KMT2A
Hydrochloric Acid SCHEMBL10536928 1.00 ACE (0.59) ACELMNAABCB11MEN1KMT2A
Hydrochloric Acid SCHEMBL10805880 1.00 ACE (0.59) ACELMNAABCB11MEN1KMT2A
SCHEMBL497515 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A
SCHEMBL1221172 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A
SCHEMBL4669890 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A
SCHEMBL4669921 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A
SCHEMBL3780597 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A
SCHEMBL28866775 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A
SCHEMBL3369452 0.99 ACE (0.60) ACELMNAABCB11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4532342-A N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids WARNER-LAMBERT COMPANY (US) 1985-07-30 US claimed
EP-0088341-B1 SUBSTITUTED ACYL DERIVATIVE OF OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID WARNER-LAMBERT COMPANY (US) 1987-07-22 EP disclosed
EP-0049605-B1 SUBSTITUTED ACYL DERIVATIVES OF 1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACIDS, SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR SALTS, AND THE PRODUCTION OF THE SAME WARNER-LAMBERT COMPANY (US) 1987-03-18 EP disclosed
US-4532342-A N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids WARNER-LAMBERT COMPANY (US) 1985-07-30 US disclosed
US-4490386-A Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof WARNER-LAMBERT COMPANY (US) 1984-12-25 US disclosed
EP-0058567-B1 SUBSTITUTED ACYL DERIVATIVES OF OCTAHYDRO-1H-ISOINDOLE-1-CARBOXYLIC ACIDS AND ESTERS WARNER-LAMBERT COMPANY (US) 1984-07-25 EP disclosed
US-4425355-A HYPOTENSIVE WARNER-LAMBERT COMPANY (US) 1984-01-10 US disclosed
EP-0096157-A2 Substituted acyl derivatives of 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid WARNER-LAMBERT COMPANY (US) 1983-12-21 EP disclosed
EP-0088341-A1 Substituted acyl derivative of octahydro-1H-indole-2-carboxylic acid WARNER-LAMBERT COMPANY (US) 1983-09-14 EP disclosed
EP-0088342-A1 Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids WARNER-LAMBERT COMPANY (US) 1983-09-14 EP disclosed
US-4350704-A HYPOTENSIVE AGENTS WARNER-LAMBERT COMPANY (US) 1982-09-21 US disclosed
EP-0058567-A1 Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids and esters WARNER-LAMBERT COMPANY (US) 1982-08-25 EP disclosed
US-4344949-A Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids WARNER-LAMBERT COMPANY (US) 1982-08-17 US disclosed
EP-0049605-A1 Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same WARNER-LAMBERT COMPANY (US) 1982-04-14 EP disclosed
EP-0037231-A2 Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids WARNER-LAMBERT COMPANY (US) 1981-10-07 EP disclosed